NCT04836728 2025-03-13
CCICC-002b
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Active not recruiting
Clinical Trials
4 trialsNCT06045767 2024-06-03
T-Cell Repertoire Sequencing: Assessing Pembrolizumab Efficacy in Advanced Non-small Lung Cancer
Tel Aviv Medical Center
Phase 2 Not yet recruiting
NCT02299765 2017-11-27
Intercalating and Maintenance Gefitinib in Combination With Chemotherapy for Advanced EGFR-mutant NSCLC
Sichuan University
Phase 4 Terminated
NCT01966003 2017-10-19
Efficacy and Safety Study of ABP 215 Compared With Bevacizumab in Patients With Advanced Non-Small Cell Lung Cancer
Amgen
Phase 3 Completed